Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Lantheus stock
Learn how to easily invest in Lantheus stock.
Lantheus Holdings Inc is a diagnostics & research business based in the US. Lantheus shares (LNTH) are listed on the NASDAQ and all prices are listed in US Dollars. Lantheus employs 595 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Lantheus
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LNTH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Lantheus stock price (NASDAQ: LNTH)Use our graph to track the performance of LNTH stocks over time.
Lantheus shares at a glance
|Latest market close||$27.29|
|52-week range||$15.20 - $31.60|
|50-day moving average||$28.16|
|200-day moving average||$25.37|
|Wall St. target price||$36.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.51|
Buy Lantheus shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Lantheus stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Lantheus price performance over time
|1 week (2022-01-12)||1.15%|
|1 month (2021-12-17)||0.55%|
|3 months (2021-10-19)||17.88%|
|6 months (2021-07-19)||7.06%|
|1 year (2021-01-19)||74.94%|
|2 years (2020-01-17)||44.28%|
|3 years (2019-01-18)||64.70%|
|5 years (2017-01-18)||195.03%|
Is Lantheus stock undervalued or overvalued?
Valuing Lantheus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Lantheus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Lantheus's PEG ratio
Lantheus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.61. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Lantheus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Lantheus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $40.8 million.
The EBITDA is a measure of a Lantheus's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$389.8 million|
|Operating margin TTM||0.64%|
|Gross profit TTM||$146.1 million|
|Return on assets TTM||0.18%|
|Return on equity TTM||-6.81%|
|Market capitalisation||$1.8 billion|
TTM: trailing 12 months
Lantheus share dividends
We're not expecting Lantheus to pay a dividend over the next 12 months.
Lantheus share price volatility
Over the last 12 months, Lantheus's shares have ranged in value from as little as $15.2 up to $31.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lantheus's is 1.3077. This would suggest that Lantheus's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic agents and products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; and RELISTOR for opioid-induced constipation. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical. It provides Thallium-201 to detect cardiovascular disease; Gallium-67 to detect various infections and cancerous tumors; and Quadramet for severe bone pain associated with osteoblastic metastatic bone lesions. The company also develops PyL for prostate cancer; flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroendocrine tumors; PSMA TTC, a thorium-227 labeled PSMA-targeted antibody therapeutic; 1404, a Tc-99m labeled small molecule; PSMA-AI, an AI-based imaging analysis technology; and leronlimab, an investigational humanized monoclonal antibody. It serves radiopharmacies, PET manufacturing facilities, integrated delivery networks, hospitals, clinics, and group practices.
Lantheus in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Joe Manchin's former aides gain influential lobbying clients as their ex-boss battles Biden's agenda
Frequently asked questionsWhat percentage of Lantheus is owned by insiders or institutions?
Currently 2.583% of Lantheus shares are held by insiders and 95.374% by institutions. How many people work for Lantheus?
Latest data suggests 595 work at Lantheus. When does the fiscal year end for Lantheus?
Lantheus's fiscal year ends in December. Where is Lantheus based?
Lantheus's address is: 331 Treble Cove Road, North Billerica, MA, United States, 01862 What is Lantheus's ISIN number?
Lantheus's international securities identification number is: US5165441032 What is Lantheus's CUSIP number?
Lantheus's Committee on Uniform Securities Identification Procedures number is: 516544103
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Ask an Expert